Approval · Notice of Compliance 13099 · 2012
AVA-MEMANTINE: Notice of Compliance 13099
Issued March 15, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13099
- Date
- March 15, 2012
- Company
- Avanstra IncCalgary, Alberta, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- N-methyl-D-aspartate Receptor Antagonist
- Canadian reference product
- EBIXA (Lundbeck Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AVA-MEMANTINE | 02376334 | — |
Medicinal ingredients
- MEMANTINE HYDROCHLORIDE 10 MG per TAB